Lecanemab is approved by MHRA in Great Britain, and restricted in NHS
Following today’s announcements from the MHRA and NICE about a new drug, lecanemab – which approve its use in Great Britain, but block its adoption in NHS England – our CEO and Founder, Prof Craig Ritchie has responded.
